论文信息 - Emerging Clinical Activity of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Follicular Lymphoma (FL), Diffuse Large B-Cell Lymphoma (DLBCL), and Other B-Cell Non-Hodgkin Lymphoma (B-NHL) Subtypes - 字舞流文

Emerging Clinical Activity of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Follicular Lymphoma (FL), Diffuse Large B-Cell Lymphoma (DLBCL), and Other B-Cell Non-Hodgkin Lymphoma (B-NHL) Subtypes

R. Advani | S. Ansell | I. Lowy | M. Ufkin | G. Thurston | S. O'brien | D. Sternberg | Jennifer R. Brown | J. Chavez | S. Ambati | R. Bannerji | V. Janković | M. Topp | S. Hamon | J. Duell | J. Barnes | L. Adriaens | J. Allan | J. Arnason | R. Charnas | Jingjin Li | N. Fiaschi | Wen Zhang | Xiaoyu Yan | P. Gasparini | Mark Navarro